The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD
Two years of the Australian Rare Cancer Portal: a national referral service for rare cancer information and research.
 
Chloe L. Georgiou
No Relationships to Disclose
 
Damien Kee
No Relationships to Disclose
 
Lia Papadopoulos
Honoraria - MSD
Travel, Accommodations, Expenses - AstraZeneca/Merck; MSD; Novartis; Novartis
 
Reece Caldwell
No Relationships to Disclose
 
Allison Bourne
No Relationships to Disclose
 
Javier Haurat
No Relationships to Disclose
 
Maureen Turner
No Relationships to Disclose
 
David Goldstein
Honoraria - Sun Biopharma
Consulting or Advisory Role - Seagen; sun biopharma
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); pfizer (Inst); Zucero Therapeutics (Inst)
 
Clare L. Scott
Consulting or Advisory Role - Oncology One
Research Funding - AstraZeneca; Clovis Oncology; Eisai; Sierra Oncology
Patents, Royalties, Other Intellectual Property - Royalty agreement for venetoclax (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Eisai; Epsila Bio; GlaxoSmithKline; MSD Oncology; Sierra Oncology; Takeda